Carrier-free Nanodrug for the Chemical-Photodynamic Synergistic Treatment of Lung Cancer DOI
Yingying Liao, Jiahui Ye, Luoyijun Xie

и другие.

ACS Applied Nano Materials, Год журнала: 2024, Номер 7(5), С. 5628 - 5636

Опубликована: Фев. 22, 2024

The theophylline derivative d17 is a candidate drug for nonsmall cell lung cancer (NSCLC) treatment previously developed by our group. However, it has the limitations of inadequate bioavailability, poor targeting, and insignificant therapeutic effect. Chemo-photodynamic synergistic therapy promising method antitumor therapy. Herein, photosensitizer chlorin e6 (Ce6) were loaded into nanoparticles (NPs) via supramolecular self-assembly, which are self-assembled through π–π stacking hydrogen bond interactions to form nanospheres with size about 85 nm surface charge −33 mV. Compared free Ce6, d17–Ce6 NPs have good hydrophilicity stability can effectively accumulate in NSCLC tumor tissues due enhancement retention More significantly, synergistically inhibit growth compared other groups no obvious toxicity. Taken together, may be an effective carrier-free nanodrug chemo-photodynamic NSCLC.

Язык: Английский

Exploring Nanocarriers as Treatment Modalities for Skin Cancer DOI Creative Commons

Mohammad Adnan,

Md Habban Akhter, Obaid Afzal

и другие.

Molecules, Год журнала: 2023, Номер 28(15), С. 5905 - 5905

Опубликована: Авг. 5, 2023

Cancer is a progressive disease of multi-factorial origin that has risen worldwide, probably due to changes in lifestyle, food intake, and environmental as some the reasons. Skin cancer can be classified into melanomas from melanocytes nonmelanoma skin (NMSC) epidermally-derived cell. Together it constitutes about 95% cancer. Basal cell carcinoma (BCC) cutaneous squamous (CSCC) are creditworthy 99% NMSC limited accessibility conventional formulations cells having multiple obstacles treatment reply this therapeutic regime. Despite this, often encounters erratic bioavailability absorption target. Nanoparticles developed through nanotechnology platforms could better topical therapy option. To improve delivery, nano-sized delivery system appropriate fuses with layer fluidized membrane; thus, deeper penetration therapeutics possible reach target spot. This review briefly outlooks various nanoparticle preparations, i.e., liposomes, niosomes, ethosomes, transferosomes, transethosomes, nanoemulsions, nanoparticles technologies tested impede their progress tend concentrate layers. Nanocarriers have proved they considerably boost medication bioavailability, lowering frequency dosage reducing toxicity associated high doses medication.

Язык: Английский

Процитировано

28

Ce6 nanoassemblies: Molecular mechanism and strategies for combinational anticancer therapy DOI Creative Commons
Yuwei Liu, Shuting Xu,

Qingyang Lyu

и другие.

Aggregate, Год журнала: 2023, Номер 5(1)

Опубликована: Окт. 12, 2023

Abstract Nowadays, cancer has become the leading cause of death worldwide, driving need for effective therapeutics to improve patient prognosis. Photodynamic therapy (PDT) been widely applied as an antitumor modality, owing its minimal invasiveness, localized tumor damage, and high safety profile. However, efficacy is limited by poor stability photosensitizers, inadequate accumulation, a complex microenvironment. To overcome these challenges, extensive endeavors have made explore co‐assembly used photosensitizer chlorin e6 (Ce6) with various functional small molecules enhance pharmacodynamic activity. This review provides comprehensive overview current studies on Ce6‐based nanoparticles PDT precise delivery molecules. The self‐assembly mechanism will be discussed in detail, focus potential strategies combinational PDT.

Язык: Английский

Процитировано

24

Recent Advances in Reprogramming Strategy of Tumor Microenvironment for Rejuvenating Photosensitizers‐Mediated Photodynamic Therapy DOI
Qing Yu, Xia Li, Juan Wang

и другие.

Small, Год журнала: 2023, Номер 20(16)

Опубликована: Ноя. 28, 2023

Abstract Photodynamic therapy (PDT) has recently been considered a potential tumor due to its time‐space specificity and non‐invasive advantages. PDT can not only directly kill cells by using cytotoxic reactive oxygen species but also induce an anti‐tumor immune response causing immunogenic cell death of cells. Although it exhibits promising prospect in treating tumors, there are still many problems be solved practical application. Tumor hypoxia immunosuppressive microenvironment seriously affect the efficacy PDT. The hypoxic is mainly abnormal vascular matrix around tumor, metabolism, influence various immunosuppressive‐related their expressed molecules. Thus, reprogramming (TME) great significance for rejuvenating This article reviews latest strategies PDT, from regulating matrix, interfering with related factors reverse microenvironment. These provide valuable information better understanding TME guide development next‐generation multifunctional nanoplatforms

Язык: Английский

Процитировано

24

Natural-product-based, carrier-free, noncovalent nanoparticles for tumor chemo-photodynamic combination therapy DOI Creative Commons
Zhonglei Wang, Liyan Yang

Pharmacological Research, Год журнала: 2024, Номер 203, С. 107150 - 107150

Опубликована: Март 21, 2024

Cancer, with its diversity, heterogeneity, and complexity, is a significant contributor to global morbidity, disability, mortality, highlighting the necessity for transformative treatment approaches. Photodynamic therapy (PDT) has aroused continuous interest as viable alternative conventional cancer treatments that encounter drug resistance. Nanotechnology brought new advances in medicine shown great potential delivery treatment. For precise efficient therapeutic utilization of such tumor approach high spatiotemporal selectivity minimal invasiveness, carrier-free noncovalent nanoparticles (NPs) based on chemo-photodynamic combination essential. Utilizing natural products foundation nanodrug development offers unparalleled advantages, including exceptional pharmacological activity, easy functionalization/modification, well biocompatibility. The natural-product-based, carrier-free, NPs revealed excellent synergistic anticancer activity comparison free photosensitizers bioactive products, representing an favorable avenue improve efficacy. Herein, comprehensive summary current strategies representative application examples past decade (such paclitaxel, 10-hydroxycamptothecin, doxorubicin, etoposide, combretastatin A4, epigallocatechin gallate, curcumin) therapy. We highlight insightful design synthesis smart aim enhance PDT Meanwhile, we discuss future challenges opportunities associated these provide enlightenment, spur innovative ideas, facilitate PDT-mediated clinical transformation.

Язык: Английский

Процитировано

15

Self-assembly strategies of organic small-molecule photosensitizers for photodynamic therapy DOI

Xiaohui Xiong,

Jingyuan Liu,

Lei Wu

и другие.

Coordination Chemistry Reviews, Год журнала: 2024, Номер 510, С. 215863 - 215863

Опубликована: Апрель 5, 2024

Язык: Английский

Процитировано

15

Metal-organic coordinated self-assembled nanomedicine for enhanced cuproptosis-mediated chemo-photo-chemodynamic synergistic therapy of non-small cell lung cancer DOI
R.P. Liu,

Ruirui Zhao,

Zi-Wei Yu

и другие.

Chemical Engineering Journal, Год журнала: 2025, Номер unknown, С. 161305 - 161305

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

1

Self-Propelling Intelligent Nanomotor: A Dual-Action Photothermal and Starvation Strategy for Targeted Deep Tumor Destruction DOI
Ling Mei, Qihang Ding,

Yuxin Xie

и другие.

Biomaterials, Год журнала: 2024, Номер 315, С. 122968 - 122968

Опубликована: Ноя. 15, 2024

Язык: Английский

Процитировано

7

A self‐assembled nanomedicine for glucose supply interruption‐amplified low‐temperature photothermal therapy and anti‐prometastatic inflammatory processes of triple‐negative breast cancer DOI Creative Commons
Mingcheng Wang,

Huixi Yi,

Zhixiong Zhan

и другие.

Aggregate, Год журнала: 2024, Номер unknown

Опубликована: Июнь 25, 2024

Abstract The poor prognosis of triple‐negative breast cancer (TNBC) results from its high metastasis, whereas inflammation accompanied by excessive reactive oxygen species (ROS) is prone to aggravate tumor metastasis. Although photothermal therapy (PTT) has extremely therapeutic efficiency, the crafty cells allow an increase in expression heat shock proteins (HSPs) limit effect, and PTT‐induced also thought be a potential trigger for Herein, myricetin, iron ions, polyvinylpyrrolidone were utilized develop nanomedicines self‐assembly strategy treatment metastatic TNBC. with marvelous water solubility dispersion can inhibit glucose transporter 1 interfere mitochondrial function block energy supply cells, achieving starvation on TNBC cells. Nanomedicines excellent conversion properties down‐regulating HSPs enhance effect PTT. Interestingly, broad spectrum ROS scavenging ability successfully attenuates as well influences hypoxia‐inducible factors‐1α/3‐phosphoinositide‐dependent protein kinase related pathway through glycometabolism inhibition reduce cell Moreover, have negligible side effects good clinical application prospects, which provides valuable paradigm interference, anti‐inflammation, starvation, synergistic therapy.

Язык: Английский

Процитировано

6

Advances and perspectives in phototherapy-based combination therapy for cancer treatment DOI

Jianing Yi,

Luyao Liu, Wenjie Gao

и другие.

Journal of Materials Chemistry B, Год журнала: 2024, Номер 12(26), С. 6285 - 6304

Опубликована: Янв. 1, 2024

Phototherapy, including photothermal therapy (PTT) and photodynamic (PDT), has the advantages of spatiotemporal selectivity, non-invasiveness, negligible drug resistance. Phototherapy been approved for treating superficial epidermal tumors. However, its therapeutic efficacy is limited by hypoxic tumor microenvironment highly expressed heat shock protein. Moreover, poor tissue penetration focused irradiation laser region in phototherapy make deep tissues metastatic tumors challenging. Combination strategies, which integrate each treatment overcome their disadvantages, can significantly improve efficacy. Recently, many combination strategies have reported. Our study summarizes used combining with other cancer treatments such as chemotherapy, immunotherapy, sonodynamic therapy, gas starvation chemodynamic therapy. Some research cases were selected to analyze effect, delivery platform feature, synergetic anticancer mechanisms. additional are summarized tables. This review provides strong evidence that phototherapy-based enhance effect compared alone. Additionally, challenges future perspectives associated these combinational therapies discussed.

Язык: Английский

Процитировано

5

Coacervation‐Driven Semipermeable Nanoreactors for Enzymatic Cascade‐Mediated Cancer Combination Therapy with Enhanced Efficacy DOI
Min Lin,

Xueli Lv,

Hepeng Wang

и другие.

Advanced Materials, Год журнала: 2024, Номер unknown

Опубликована: Сен. 5, 2024

Abstract Utilizing enzyme cascades as a promising approach for targeted cancer therapies holds significant potential, yet its clinical effectiveness is substantially hindered by functional losses during delivery. Complex coacervation emerges an intriguing strategy designing nanoreactors. In this study, noteworthy achievement presented in the development of lactobionic acid‐modified tumor microenvironment (TME)‐responsive polyelectrolyte complex vesicles (HGS‐PCVs) based on bioinspired homopolypeptoids, which serve facile, intelligent, and highly efficient nanoreactor tunable glucose oxidase, hemoglobin, sorafenib (SRF) to hepatic cells. The TME‐responsive permeability HGS‐PCVs enables selective entry into their interior, triggering enzymatic cascade reaction within tumor. This intricate process generates toxic hydroxyl radicals while concurrently lowering pH. Consequently, pH shift enhances SRF release, effectively promoting ferroptosis apoptosis target Further, administration not only initiates immunogenic cell death but also plays crucial role inducing maturation dendritic cells lymph nodes. It stimulates adaptive T‐cell response, mechanism that contributes impeding growth distant tumors vivo, demonstrating potential PCVs immunotherapy.

Язык: Английский

Процитировано

5